Status:
RECRUITING
Effect of Breather in COPD Patients with Intermittent Claudication
Lead Sponsor:
Cairo University
Conditions:
COPD
PAD
Eligibility:
MALE
50-60 years
Phase:
NA
Brief Summary
The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
Detailed Description
recent researches show that COPD patients have risk of developing peripheral arterial disease (PAD) which represented on patient by intermittent claudication inspiratory muscle trainer as the breather...
Eligibility Criteria
Inclusion
- sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
- All patients will be clinically and medically stable when attending the study.
- Body mass index (BMI) is 18.5 to 24.9 kg/m2.
- History of unilateral exertional leg pain,
- Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
- And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.
Exclusion
- cardiovascular insufficiency,
- Recent myocardial infarction,
- heart failure,
- arrhythmia,
- DVT,
- Intracranial hypertension,
- Pneumonia,
- kidney failure,
- fractures,
- uncooperative patients,
- cognitive impairment preventing a patient from participation in exercises.
Key Trial Info
Start Date :
July 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06529185
Start Date
July 30 2024
End Date
February 1 2025
Last Update
December 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy
Dokki, Egypt